JP7629692B2 - Method for producing porous cellulose beads - Google Patents
Method for producing porous cellulose beads Download PDFInfo
- Publication number
- JP7629692B2 JP7629692B2 JP2020064177A JP2020064177A JP7629692B2 JP 7629692 B2 JP7629692 B2 JP 7629692B2 JP 2020064177 A JP2020064177 A JP 2020064177A JP 2020064177 A JP2020064177 A JP 2020064177A JP 7629692 B2 JP7629692 B2 JP 7629692B2
- Authority
- JP
- Japan
- Prior art keywords
- cellulose
- solution
- beads
- cellulose beads
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000001913 cellulose Substances 0.000 title claims description 159
- 229920002678 cellulose Polymers 0.000 title claims description 154
- 239000011324 bead Substances 0.000 title claims description 111
- 238000004519 manufacturing process Methods 0.000 title claims description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 117
- 239000000243 solution Substances 0.000 claims description 78
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 69
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 49
- 239000002904 solvent Substances 0.000 claims description 32
- 239000004202 carbamide Substances 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 22
- 238000004132 cross linking Methods 0.000 claims description 19
- 239000000839 emulsion Substances 0.000 claims description 17
- 230000015271 coagulation Effects 0.000 claims description 15
- 238000005345 coagulation Methods 0.000 claims description 15
- 239000002612 dispersion medium Substances 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 12
- 239000005456 alcohol based solvent Substances 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 7
- 229920000875 Dissolving pulp Polymers 0.000 claims description 6
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 235000010980 cellulose Nutrition 0.000 description 141
- 238000006243 chemical reaction Methods 0.000 description 30
- 239000007864 aqueous solution Substances 0.000 description 25
- 239000011148 porous material Substances 0.000 description 24
- 238000001179 sorption measurement Methods 0.000 description 20
- 239000003463 adsorbent Substances 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 239000012153 distilled water Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 239000000872 buffer Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000003431 cross linking reagent Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 239000002245 particle Substances 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 229920003124 powdered cellulose Polymers 0.000 description 5
- 235000019814 powdered cellulose Nutrition 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229920002307 Dextran Polymers 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 125000003172 aldehyde group Chemical group 0.000 description 4
- 239000010775 animal oil Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 4
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000019484 Rapeseed oil Nutrition 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- -1 sorbitan fatty acid esters Chemical class 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 235000019871 vegetable fat Nutrition 0.000 description 2
- DEWLEGDTCGBNGU-UHFFFAOYSA-N 1,3-dichloropropan-2-ol Chemical compound ClCC(O)CCl DEWLEGDTCGBNGU-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- ALWXETURCOIGIZ-UHFFFAOYSA-N 1-nitropropylbenzene Chemical compound CCC([N+]([O-])=O)C1=CC=CC=C1 ALWXETURCOIGIZ-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- 206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
- 201000010046 Dilated cardiomyopathy Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 241001261506 Undaria pinnatifida Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 229940125644 antibody drug Drugs 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- RJTANRZEWTUVMA-UHFFFAOYSA-N boron;n-methylmethanamine Chemical compound [B].CNC RJTANRZEWTUVMA-UHFFFAOYSA-N 0.000 description 1
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 229960002303 citric acid monohydrate Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 150000002009 diols Chemical group 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000011978 dissolution method Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 150000003944 halohydrins Chemical class 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 238000007866 imination reaction Methods 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 239000010699 lard oil Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000004170 rice bran wax Substances 0.000 description 1
- 235000019384 rice bran wax Nutrition 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 229950006451 sorbitan laurate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Processes Of Treating Macromolecular Substances (AREA)
Description
本発明は、多孔質セルロースビーズを製造するための方法に関する。 The present invention relates to a method for producing porous cellulose beads.
多孔質セルロースビーズは、他の合成系高分子を用いる場合に比べて安全性が高く、非特異的吸着が少ないという利点があり、多孔質セルロースビーズは、各種クロマトグラフィー用吸着体やアフィニティー吸着体などの各種吸着体用の基材として用いられている。特に、アフィニティー吸着体は、効率よく目的物を精製でき、且つ不要物濃度を低減できることから、医療用吸着体や抗体医薬品精製用吸着体として利用されてきている。特に、リウマチ、血友病、拡張型心筋症の治療用吸着体または医療用吸着体として、プロテインAをアフィニティーリガンドとして多孔質担体に固定化した吸着体が注目されている(例えば非特許文献1、非特許文献2)。 Porous cellulose beads have the advantage of being safer and less prone to non-specific adsorption than other synthetic polymers, and are used as a substrate for various adsorbents, such as adsorbents for various types of chromatography and affinity adsorbents. In particular, affinity adsorbents can efficiently purify the target substance and reduce the concentration of unnecessary substances, and therefore have been used as medical adsorbents and adsorbents for purifying antibody drugs. In particular, adsorbents in which protein A is immobilized as an affinity ligand on a porous carrier have attracted attention as adsorbents for treating rheumatism, hemophilia, and dilated cardiomyopathy or as medical adsorbents (e.g., Non-Patent Document 1, Non-Patent Document 2).
多孔質セルロースビーズの製造は、セルロースの溶解が困難であるとされていたことから、通常の合成ポリマーと比べて煩雑な工程を含むものが多い。その一つとして、チオシアン酸カルシウム水溶液など腐食性や毒性が高く、設備化の難易度を高くしてしまう溶媒に溶解し、凝固する方法が開示されている(例えば特許文献1)。この方法で用いられるセルロース溶液が特異な挙動を示し、また、この方法で得られる多孔質セルロースビーズは、かなり大きい細孔を有しており、また細孔径分布も広いことが知られている(例えば非特許文献3)。よって、当該方法で得られた多孔質セルロースビーズを抗体などの吸着体として用いる場合、比表面積が小さいことから、高い吸着性能を示すことは期待できない。一方、セルロースの溶解性を上げるためにセルロースの水酸基に置換基を付与し、汎用の溶媒に溶解させて造粒を行い、造粒後に置換基を脱離させて多孔質セルロース系担体を得る方法が例示されている(例えば特許文献2)が、工程が煩雑であり、置換基を付与したり脱離させたりする過程で分子量の低下が起こり、近年求められている高速処理や大スケールで使用するのに適切な機械的強度が得られ難い傾向がある。 Manufacturing porous cellulose beads involves many complicated steps compared to ordinary synthetic polymers, since it was believed that dissolving cellulose was difficult. One of these methods involves dissolving and solidifying cellulose in a highly corrosive and toxic solvent, such as an aqueous solution of calcium thiocyanate, which makes it difficult to set up equipment (e.g., Patent Document 1). It is known that the cellulose solution used in this method exhibits peculiar behavior, and that the porous cellulose beads obtained by this method have fairly large pores and a wide pore size distribution (e.g., Non-Patent Document 3). Therefore, when using the porous cellulose beads obtained by this method as an adsorbent for antibodies, etc., it is not expected to show high adsorption performance because of the small specific surface area. On the other hand, a method is exemplified in which a substituent is added to the hydroxyl group of cellulose to increase the solubility of cellulose, the cellulose is dissolved in a general-purpose solvent, granulated, and the substituent is removed after granulation to obtain a porous cellulose-based carrier (e.g., Patent Document 2). However, the process is complicated, and the molecular weight decreases during the process of adding and removing the substituent, and it tends to be difficult to obtain mechanical strength suitable for high-speed processing and large-scale use, which are required in recent years.
一方、セルロースを低温のアルカリ/尿素/水の混和溶液に溶解させる方法が報告されている(非特許文献4)。この溶解方法は環境負荷が低く、溶解工程も煩雑ではないので、種々の検討がなされている。 On the other hand, a method has been reported in which cellulose is dissolved in a low-temperature mixed solution of alkali, urea, and water (Non-Patent Document 4). This dissolution method has a low environmental impact and the dissolution process is not complicated, so various studies have been conducted on it.
本発明は、毒性・腐食性の高い副原料を使わず、工業的に不利である煩雑な工程を経ることなく簡便に、効率良く、抗体吸着に適した細孔構造を有するセルロースビーズを開発することを目的としている。 The objective of the present invention is to develop cellulose beads that have a pore structure suitable for antibody adsorption in a simple and efficient manner, without using highly toxic or corrosive secondary materials, and without going through complicated processes that are industrially disadvantageous.
本発明者らは、上記課題を解決すべく鋭意研究を行った結果、水酸化ナトリウム、水酸化リチウム、尿素及び水の混和溶液を用いることで、抗体吸着に最適な構造を持ったセルロースビーズを製造できることを見出し、本発明を完成させるに至った。 As a result of intensive research conducted by the inventors to solve the above problems, they discovered that by using a mixed solution of sodium hydroxide, lithium hydroxide, urea, and water, it is possible to produce cellulose beads with an optimal structure for antibody adsorption, which led to the completion of the present invention.
したがって、本発明の一態様は、(a)-5℃以下、-20℃以上の水酸化ナトリウム、水酸化リチウム、尿素及び水の混和溶液にセルロースを溶解させ、セルロース溶液を調製する工程、(b)前記セルロース溶液を10℃以上、40℃以下に加温する工程、(c)前記セルロース溶液を10℃以上、40℃以下の分散媒に分散させてエマルションを作製する工程、(d)前記エマルションを凝固溶媒に接触させ、セルロースビーズを析出させる工程、(e)析出したセルロースビーズを架橋する工程を含む多孔質架橋セルロースビーズの製造方法であり、前記工程(a)の水酸化ナトリウム/水酸化リチウムのモル比が0.3/0.7~0.8/0.2であることを特徴とする多孔質架橋セルロースビーズの製造方法に関する。 Therefore, one aspect of the present invention is a method for producing porous crosslinked cellulose beads, which includes the steps of: (a) dissolving cellulose in a mixed solution of sodium hydroxide, lithium hydroxide, urea, and water at -5°C or lower and -20°C or higher to prepare a cellulose solution; (b) heating the cellulose solution to 10°C or higher and 40°C or lower; (c) dispersing the cellulose solution in a dispersion medium at 10°C or higher and 40°C or lower to prepare an emulsion; (d) contacting the emulsion with a coagulation solvent to precipitate cellulose beads; and (e) crosslinking the precipitated cellulose beads, wherein the molar ratio of sodium hydroxide/lithium hydroxide in step (a) is 0.3/0.7 to 0.8/0.2.
本発明によれば、毒性・腐食性の高い副原料を使わず、工業的に不利である煩雑な工程を経ることなく簡便に、抗体吸着に適したセルロースビーズを製造することができる。 According to the present invention, cellulose beads suitable for antibody adsorption can be easily produced without using highly toxic and corrosive secondary materials and without going through complicated processes that are industrially disadvantageous.
本発明の実施の一形態について、以下に詳細に説明する。なお、本明細書において特記しない限り、数値範囲を表す「A~B」は、「A以上、B以下」を意味する。また、本明細書中に記載された文献の全てが、本明細書中において参考文献として援用される。 One embodiment of the present invention will be described in detail below. Note that unless otherwise specified in this specification, "A to B" representing a numerical range means "A or more, B or less." In addition, all documents described in this specification are incorporated herein by reference.
〔1.本発明の概要〕
本発明の一実施形態に係る多孔質セルロースビーズの製造方法(以下、「本製造方法」と称する。)は、(a)-5℃以下、-20℃以上の水酸化ナトリウム、水酸化リチウム、尿素及び水の混和溶液にセルロースを溶解させ、セルロース溶液を調製する工程、(b)前記セルロース溶液を10℃以上、40℃以下に加温する工程、(c)前記セルロース溶液を10℃以上、40℃以下の分散媒に分散させてエマルションを作製する工程、(d)前記エマルションを凝固溶媒に接触させ、セルロースビーズを析出させる工程、(e)析出したセルロースビーズを架橋する工程を含む。低温の水酸化ナトリウム水溶液にセルロースを分散させ、凝固溶媒に接触させることにより、多孔質セルロースが得られることは、本出願人により開発済である(国際公開WO2012/121258など)。
1. Overview of the Invention
The method for producing porous cellulose beads according to one embodiment of the present invention (hereinafter referred to as "this production method") includes the steps of (a) dissolving cellulose in a mixed solution of sodium hydroxide, lithium hydroxide, urea and water at -5°C or lower and -20°C or higher to prepare a cellulose solution, (b) heating the cellulose solution at 10°C or higher and 40°C or lower, (c) dispersing the cellulose solution in a dispersion medium at 10°C or higher and 40°C or lower to prepare an emulsion, (d) contacting the emulsion with a coagulation solvent to precipitate cellulose beads, and (e) crosslinking the precipitated cellulose beads. The present applicant has already developed the fact that porous cellulose can be obtained by dispersing cellulose in a low-temperature aqueous sodium hydroxide solution and contacting it with a coagulation solvent (International Publication WO2012/121258, etc.).
理由は定かではないが、驚くべきことに、本発明者らは、単種のアルカリ性物質を使用するのではなく、複数のアルカリ性物質を併用することで抗体吸着に適した細孔を持つ架橋セルロースビーズを製造できることを初めて見出した。 Although the reason is unclear, the inventors surprisingly discovered for the first time that crosslinked cellulose beads with pores suitable for antibody adsorption can be produced by using multiple alkaline substances in combination, rather than using a single type of alkaline substance.
以下、本製造方法の構成について詳説する。 The configuration of this manufacturing method is explained in detail below.
〔2.多孔質セルロースビーズの製造方法〕
本製造方法は、下記の工程(a)および工程(b)を必須の工程として含む方法である。
・工程(a):-5℃以下、-20℃以上の水酸化ナトリウム、水酸化リチウム、尿素及び水の混和溶液にセルロースを溶解させ、セルロース溶液を調製する工程
・工程(b):前記工程(a)で調製したセルロース溶液を10℃以上、40℃以下に加温する工程
・工程(c):前記工程(b)で調製したセルロース溶液を10℃以上、40℃以下の分散媒に分散させてエマルションを作製する工程
・工程(d):前記工程(c)で作製したエマルションを凝固溶媒に接触させ、セルロースビーズを析出させる工程
・工程(e):前記工程(d)で析出させたセルロースビーズを架橋する工程
以下、本発明方法を工程ごとに説明する。
2. Method for producing porous cellulose beads
The present production method includes the following steps (a) and (b) as essential steps.
Step (a): A step of dissolving cellulose in a mixed solution of sodium hydroxide, lithium hydroxide, urea and water at -5°C or lower and -20°C or higher to prepare a cellulose solution. Step (b): A step of heating the cellulose solution prepared in step (a) at 10°C or higher and 40°C or lower. Step (c): A step of dispersing the cellulose solution prepared in step (b) in a dispersion medium at 10°C or higher and 40°C or lower to prepare an emulsion. Step (d): A step of contacting the emulsion prepared in step (c) with a coagulation solvent to precipitate cellulose beads. Step (e): A step of crosslinking the cellulose beads precipitated in step (d). Each step of the method of the present invention will be explained below.
(工程(a))
本製造方法における工程(a)では、-5℃以下、-20℃以上の水酸化ナトリウム、水酸化リチウム、尿素及び水の混和溶液にセルロースを溶解させ、セルロース溶液を作製する。
(Step (a))
In step (a) of this production method, cellulose is dissolved in a mixed solution of sodium hydroxide, lithium hydroxide, urea and water at −5° C. or lower and −20° C. or higher to prepare a cellulose solution.
ここで水酸化ナトリウム/水酸化リチウムのモル比は0.3/0.7~0.8/0.2であることが好ましい。さらに好ましくは、0.4/0.6~0.7/0.3であり、より好ましくは、0.45/0.55~0.65/0.35である。水酸化ナトリウムモル比が高くなりすぎると、細孔半径が抗体吸着にとって大きくなりすぎ、水酸化ナトリウムモル比が低くなりすぎると細孔半径が抗体吸着にとって小さくなる。 Here, the molar ratio of sodium hydroxide/lithium hydroxide is preferably 0.3/0.7 to 0.8/0.2. More preferably, it is 0.4/0.6 to 0.7/0.3, and even more preferably, it is 0.45/0.55 to 0.65/0.35. If the molar ratio of sodium hydroxide is too high, the pore radius becomes too large for antibody adsorption, and if the molar ratio of sodium hydroxide is too low, the pore radius becomes too small for antibody adsorption.
本発明の一実施形態において、水酸化ナトリウム、水酸化リチウム、尿素及び水の混和溶液中の水酸化ナトリウム及び水酸化リチウムの合計濃度は5重量%~20重量%が好ましい。さらに好ましくは6重量%~15重量%であり、より好ましくは7重量%~12重量%である。上記濃度範囲であれば、セルロースを良好に溶解させることができる。 In one embodiment of the present invention, the total concentration of sodium hydroxide and lithium hydroxide in the mixed solution of sodium hydroxide, lithium hydroxide, urea and water is preferably 5% by weight to 20% by weight. More preferably, it is 6% by weight to 15% by weight, and even more preferably, it is 7% by weight to 12% by weight. If the concentration is within the above range, cellulose can be dissolved well.
本発明の一実施形態において、水酸化ナトリウム、水酸化リチウム、尿素及び水の混和溶液の尿素濃度は10重量%~20重量%であることが好ましい。さらに好ましくは11重量%~18重量%であり、より好ましくは11重量%~16重量%である。上記濃度範囲であれば、セルロースを良好に溶解させることができる。 In one embodiment of the present invention, the urea concentration of the mixed solution of sodium hydroxide, lithium hydroxide, urea and water is preferably 10% to 20% by weight. More preferably, it is 11% to 18% by weight, and even more preferably, it is 11% to 16% by weight. If the concentration is within the above range, cellulose can be dissolved well.
本発明の本発明の一実施形態において、セルロース溶液のセルロース濃度は3重量%以上、9重量%以下であることが好ましい。上記濃度範囲であれば、セルロースを良好に溶解させることができる。 In one embodiment of the present invention, the cellulose concentration of the cellulose solution is preferably 3% by weight or more and 9% by weight or less. If the concentration is within the above range, the cellulose can be dissolved well.
本発明の一実施形態において、用いるセルロース原料の分子量は特に制限されないが、重合度としては100~1000であることが好ましい。さらに好ましくは、150~900であり、より好ましくは200~800である。セルロース分子量が上記範囲であれば、セルロースが溶解しやすい。 In one embodiment of the present invention, the molecular weight of the cellulose raw material used is not particularly limited, but the degree of polymerization is preferably 100 to 1000. More preferably, it is 150 to 900, and even more preferably, it is 200 to 800. If the cellulose molecular weight is within the above range, the cellulose is easily dissolved.
本発明の一実施形態において、セルロース溶液の温度は-5℃~-20℃であることが好ましい。さらに好ましくは、-8℃~-19℃であり、より好ましくは-10℃~-17℃である。-5℃以上の温度であれば、セルロースが溶解しにくく、-20℃以下であれば、セルロース溶液が凍結してしまい、操作性が悪くなる。 In one embodiment of the present invention, the temperature of the cellulose solution is preferably -5°C to -20°C. More preferably, it is -8°C to -19°C, and even more preferably -10°C to -17°C. If the temperature is -5°C or higher, the cellulose is difficult to dissolve, and if the temperature is -20°C or lower, the cellulose solution freezes, making it difficult to handle.
(工程(b))
本製造方法における工程(b)では、工程(a)で調製したセルロース溶液を加温し、10℃~40℃とする。さらに好ましくは、15℃~30℃であり、より好ましくは20℃~28℃である。加温温度が上記範囲であれば、セルロースが析出せず、また溶液粘性が高くならないので、好適に操作することができる。
(Step (b))
In step (b) of the present production method, the cellulose solution prepared in step (a) is heated to 10° C. to 40° C. More preferably, the temperature is 15° C. to 30° C., and even more preferably, 20° C. to 28° C. If the heating temperature is within the above range, cellulose does not precipitate and the solution viscosity does not increase, so that the operation can be carried out suitably.
(工程(c))
本製造方法における工程(c)では、工程(b)で調製したセルロース溶液を分散媒に分散させてエマルションを作製する。
(Step (c))
In step (c) of this production method, the cellulose solution prepared in step (b) is dispersed in a dispersion medium to prepare an emulsion.
本発明の一実施形態において、分散媒はセルロース溶液と混和しなければ特に制限されないが、例えば、炭化水素系溶媒、動植物油脂、水素添加動植物油脂、脂肪酸グリセリド、脂肪族炭化水素系溶媒、芳香族炭化水素系溶媒を挙げることができる。また、非イオン界面活性剤などの界面活性剤を分散媒に添加してもよい。 In one embodiment of the present invention, the dispersion medium is not particularly limited as long as it is not miscible with the cellulose solution, but examples include hydrocarbon solvents, animal and vegetable oils and fats, hydrogenated animal and vegetable oils and fats, fatty acid glycerides, aliphatic hydrocarbon solvents, and aromatic hydrocarbon solvents. In addition, a surfactant such as a nonionic surfactant may be added to the dispersion medium.
炭化水素系溶媒としては、ヘキサン、デカン、流動パラフィンなどを挙げることができる。動植物油脂としては、パーム油、シア脂、サル脂、イリッペ脂、豚脂、牛脂、ナタネ油、米油、落花生油、オリーブ油、コーン油、大豆油、シソ油、綿実油、ヒマワリ油、月見草油、ゴマ油、サフラワー油、ヤシ油、カカオ脂、パーム核油、魚油、ワカメ油、コンブ油などを挙げることができる。水素添加動植物油脂としては、パーム硬化油、パーム極度硬化油、ナタネ硬化油、ナタネ極度硬化油、大豆硬化油、豚脂硬化油、魚油硬化油などを挙げることができる。脂肪酸グリセリドとしては、トリ-、ジ-、モノ-グリセリドのいずれでもよく、ステアリングリセリド、パルミチングリセリド、ラウリングリセリドなどを挙げることができる。脂肪族炭化水素系溶媒としては、ミツロウ、キャンデリラロウ、米ぬかロウなどを挙げることができる。芳香族炭化水素系溶媒としては、ベンゼン、トルエン、クロロベンゼン、ジクロロベンゼンなどを挙げることができる。 Examples of hydrocarbon solvents include hexane, decane, and liquid paraffin. Examples of animal and vegetable oils include palm oil, shea butter, monkey fat, illipe fat, lard, beef tallow, rapeseed oil, rice oil, peanut oil, olive oil, corn oil, soybean oil, perilla oil, cottonseed oil, sunflower oil, evening primrose oil, sesame oil, safflower oil, coconut oil, cacao butter, palm kernel oil, fish oil, wakame oil, and kelp oil. Examples of hydrogenated animal and vegetable oils include hardened palm oil, extremely hardened palm oil, hardened rapeseed oil, extremely hardened rapeseed oil, hardened soybean oil, hardened lard oil, and hardened fish oil. Examples of fatty acid glycerides include tri-, di-, and mono-glycerides, and examples of such glycerides include stearyl glyceride, palmitic glyceride, and lauric glyceride. Aliphatic hydrocarbon solvents include beeswax, candelilla wax, rice bran wax, etc. Aromatic hydrocarbon solvents include benzene, toluene, chlorobenzene, dichlorobenzene, etc.
エマルション作製のために、さらに界面活性剤を分散媒に適量添加してもよい。界面活性剤としては、ソルビタンラウレート、ソルビタンステアレート、ソルビタンオレエート、ソルビタントリオレエートなどのソルビタン脂肪酸エステル、ポリグリセリンポリリシノレート、デカグリセリンオレート、デカグリセリンステアレートなどのポリグリセリン脂肪酸エステルを挙げることができる。 To prepare an emulsion, a suitable amount of a surfactant may be added to the dispersion medium. Examples of surfactants include sorbitan fatty acid esters such as sorbitan laurate, sorbitan stearate, sorbitan oleate, and sorbitan trioleate, and polyglycerin fatty acid esters such as polyglycerin polyricinoleate, decaglycerin oleate, and decaglycerin stearate.
本発明の一実施形態において、分散媒の使用量は特に限定されないが、工程(b)で調製したセルロース溶液を十分に分散できる量とすればよい。例えば、前記セルロース溶液に対して1体積倍~10体積倍とすることができる。より好ましくは2体積倍~8体積倍であり、より好ましくは4体積倍~10体積倍である。前記範囲外の分散媒使用量となると廃液量が過剰に増えるおそれがあり得る。 In one embodiment of the present invention, the amount of the dispersion medium used is not particularly limited, but may be an amount that can sufficiently disperse the cellulose solution prepared in step (b). For example, the amount may be 1 to 10 times the volume of the cellulose solution. More preferably, the amount is 2 to 8 times, and more preferably, the amount is 4 to 10 times. If the amount of the dispersion medium used is outside the above range, there is a risk of excessive increase in the amount of waste liquid.
エマルションは、常法により調製すればよい。例えば、前記セルロース溶液、分散媒および界面活性剤を含む混合液を激しく攪拌することにより調製することができる。 The emulsion may be prepared by a conventional method. For example, it may be prepared by vigorously stirring a mixture containing the cellulose solution, a dispersion medium, and a surfactant.
(工程(d))
本製造方法における工程(d)では、工程(c)で調製したエマルションに凝固溶媒を接触させて多孔質セルロースビーズを作製する。
(Step (d))
In step (d) of this production method, the emulsion prepared in step (c) is brought into contact with a coagulation solvent to produce porous cellulose beads.
凝固溶媒は、セルロース溶液に親和性を示すものであれば特に制限されないが、例えば、アルコール系溶媒、または水とアルコール系溶媒との混合溶媒を挙げることができる。アルコール系溶媒としては、メタノール、エタノール、n-プロパノール、イソプロパノール、n-ブタノール、イソブタノール、s-ブタノール、t-ブタノールなどのC1-4アルコールを挙げることができる。水とアルコール系溶媒との混合溶媒における水とアルコール系溶媒の割合は、例えば、体積比で水:アルコール系溶媒=80:20~1:99とすることができる。 The coagulation solvent is not particularly limited as long as it has affinity for the cellulose solution, and examples thereof include alcohol-based solvents and mixed solvents of water and alcohol-based solvents. Examples of alcohol-based solvents include C1-4 alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, s-butanol, and t-butanol. The ratio of water to alcohol-based solvent in the mixed solvent of water and alcohol-based solvent can be, for example, 80:20 to 1:99 by volume.
本発明の一実施形態において、凝固方法は特に制限されないが、エマルションは不安定である場合があるので、液滴同士が結合しないよう激しく攪拌した状態で凝固溶媒を添加することが好ましい。 In one embodiment of the present invention, the coagulation method is not particularly limited, but since the emulsion may be unstable, it is preferable to add the coagulation solvent while vigorously stirring the emulsion to prevent the droplets from bonding together.
凝固溶媒を添加した後は、凝固した多孔質セルロースビーズを濾過や遠心分離などにより分離し、水やアルコールなどで洗浄すればよい。得られた多孔質セルロースビーズは、粒径を揃えるため、篩などを用いて分級してもよい。 After the coagulation solvent is added, the coagulated porous cellulose beads can be separated by filtration or centrifugation, and washed with water or alcohol. The resulting porous cellulose beads can be classified using a sieve to make the particle size uniform.
(工程(e))
本製造方法における工程(e)では、工程(d)で作製したセルロースビーズに、架橋剤により架橋して多孔質架橋セルロースビーズを作製する。
(Step (e))
In step (e) of this production method, the cellulose beads produced in step (d) are crosslinked with a crosslinking agent to produce porous crosslinked cellulose beads.
架橋剤は、セルロース上の水酸基と共有結合を形成できる反応性基を2以上有し、セルロース分子間を架橋できるものをいう。本発明で用いることができる架橋多孔質セルロース粒子の架橋の条件や架橋剤に特に限定は無い。例えばWO2008/146906に記載の方法を用いることができる。この国際公報の全内容が、本願に参考のため援用される。 The crosslinking agent has two or more reactive groups capable of forming covalent bonds with hydroxyl groups on cellulose and is capable of crosslinking between cellulose molecules. There are no particular limitations on the crosslinking conditions or crosslinking agents for the crosslinked porous cellulose particles that can be used in the present invention. For example, the method described in WO2008/146906 can be used. The entire contents of this international publication are incorporated herein by reference.
架橋剤としては、例えば、エピクロロヒドリン、エピブロモヒドリン、ジクロロヒドリンなどのハロヒドリン;2官能性ビスエポキシド(ビスオキシラン);多官能性ポリエポキシド(ポリオキシラン)を挙げることができる。架橋剤は、一種のみを単独で用いてもよいし、二種以上を併用してもよい。 Examples of crosslinking agents include halohydrins such as epichlorohydrin, epibromohydrin, and dichlorohydrin; bifunctional bisepoxides (bisoxiranes); and polyfunctional polyepoxides (polyoxiranes). Only one type of crosslinking agent may be used alone, or two or more types may be used in combination.
多孔質セルロースビーズを架橋剤により架橋する反応の溶媒は適宜選択すればよいが、例えば、水の他、メタノール、エタノール、イソプロパノールなどのアルコール系溶媒や、アセトニトリルなどのニトリル系溶媒などの水混和性有機溶媒を挙げることができる。また、架橋反応溶媒は、2以上を混合して用いてもよい。 The solvent for the reaction in which the porous cellulose beads are crosslinked with a crosslinking agent may be selected as appropriate, and examples of the solvent include water, as well as water-miscible organic solvents such as alcohol-based solvents such as methanol, ethanol, and isopropanol, and nitrile-based solvents such as acetonitrile. In addition, two or more crosslinking reaction solvents may be mixed together.
架橋反応は、複数回実施してもよく、各回で反応溶媒や架橋剤を変更してもよい。例えば、1回目の架橋反応を水混和性有機溶媒中で行い、最終回の架橋反応を水中で行ってもよい。この場合、途中の溶媒組成は、1回目と最終回のどちらかと同じであっても異なっていてもよく、それらの中間組成であってもよい。さらには全ての回を水溶媒中で実施してもよい。架橋剤についても同様である。なお、架橋反応を複数回繰り返す場合、各架橋反応の間では、架橋多孔質セルロースビーズを水などで洗浄して架橋剤を除去することが好ましい。 The crosslinking reaction may be carried out multiple times, and the reaction solvent or crosslinking agent may be changed each time. For example, the first crosslinking reaction may be carried out in a water-miscible organic solvent, and the final crosslinking reaction may be carried out in water. In this case, the solvent composition during the reaction may be the same as or different from either the first or final reaction, or may be an intermediate composition between the first and final reactions. Furthermore, all the reactions may be carried out in an aqueous solvent. The same applies to the crosslinking agent. When the crosslinking reaction is repeated multiple times, it is preferable to remove the crosslinking agent by washing the crosslinked porous cellulose beads with water or the like between each crosslinking reaction.
架橋反応を促進するために、反応液には塩基を添加してもよい。かかる塩基としては、水酸化ナトリウムや水酸化カリウムなどのアルカリ金属水酸化物;炭酸水素ナトリウムや炭酸水素カリウムなどアルカリ金属の炭酸水素塩;炭酸ナトリウムや炭酸カリウムなどアルカリ金属の炭酸塩;トリエチルアミンやピリジンなどの有機塩基を挙げることができる。 To promote the crosslinking reaction, a base may be added to the reaction solution. Examples of such bases include alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; alkali metal bicarbonates such as sodium bicarbonate and potassium bicarbonate; alkali metal carbonates such as sodium carbonate and potassium carbonate; and organic bases such as triethylamine and pyridine.
架橋反応後は、多孔質架橋セルロースビーズは不溶性であることから、水などの溶媒で洗浄すればよい。 After the crosslinking reaction, the porous crosslinked cellulose beads are insoluble, so they can be washed with a solvent such as water.
本製造方法によると、高い生産性で、抗体吸着に優れた架橋多孔質セルロースビーズを得ることができる。 This manufacturing method makes it possible to obtain cross-linked porous cellulose beads with excellent antibody adsorption properties with high productivity.
〔3.多孔質架橋セルロースビーズ〕
本発明の一実施形態に係る多孔質架橋セルロースビーズ(以下、「本ビーズ」と称する。)は粒子内空孔率が90%以上であり、細孔半径が35~50nmであり、体積メジアン径が45~70μmである。
3. Porous cross-linked cellulose beads
The porous cross-linked cellulose beads according to one embodiment of the present invention (hereinafter referred to as "the present beads") have an intra-particle porosity of 90% or more, a pore radius of 35 to 50 nm, and a volume median diameter of 45 to 70 μm.
本ビーズは、本製造方法により製造されるため、抗体吸着能に優れるという利点を有する。 These beads are manufactured using this manufacturing method, and therefore have the advantage of having excellent antibody adsorption capabilities.
本ビーズの体積メジアン径は、特に限定されないが、優れた動的抗体吸着能が達成されるという観点から、45~70μmが好ましく、50~65μmがより好ましく、55~63μmがさらに好ましい。本ビーズの体積メジアン径は、実施例に記載の方法により測定される。 The volume median diameter of the present beads is not particularly limited, but from the viewpoint of achieving excellent dynamic antibody adsorption capacity, it is preferably 45 to 70 μm, more preferably 50 to 65 μm, and even more preferably 55 to 63 μm. The volume median diameter of the present beads is measured by the method described in the Examples.
本ビーズの粒子内空孔率は、優れた動的抗体吸着能が達成されるという観点から、90%以上が好ましく、91%以上がより好ましく、92%以上がさらに好ましい。本ビーズの粒子内空孔率は、実施例に記載の方法により測定される。 From the viewpoint of achieving excellent dynamic antibody adsorption capacity, the intraparticle porosity of the present beads is preferably 90% or more, more preferably 91% or more, and even more preferably 92% or more. The intraparticle porosity of the present beads is measured by the method described in the Examples.
本ビーズの細孔半径は、優れた動的抗体吸着能が達成されるという観点から、35~50nmが好ましく、37~48nmがより好ましく、40~45nmがさらに好ましい。本ビーズの平均細孔半径は、実施例に記載の方法により測定される。 From the viewpoint of achieving excellent dynamic antibody adsorption capacity, the pore radius of the present beads is preferably 35 to 50 nm, more preferably 37 to 48 nm, and even more preferably 40 to 45 nm. The average pore radius of the present beads is measured by the method described in the Examples.
本ビーズは抗体を特異的に吸着させるために、プロテインAリガンドを結合させることができ、その結合条件やプロテインAリガンドに特に限定は無い。例えばWO2012/133349に記載の方法を用いることができる。この国際公報の全内容が、本願に参考のため援用される。 These beads can be bound to a protein A ligand in order to specifically adsorb the antibody, and there are no particular limitations on the binding conditions or protein A ligand. For example, the method described in WO2012/133349 can be used. The entire contents of this international publication are incorporated herein by reference.
本発明は上述した実施形態に限定されるものではなく、請求項に示した範囲で種々の変更が可能であり、異なる実施形態にそれぞれ開示された技術的手段を適宜組み合わせて得られる実施形態についても本発明の技術的範囲に含まれる。 The present invention is not limited to the above-described embodiment, and various modifications are possible within the scope of the claims. The technical scope of the present invention also includes embodiments obtained by appropriately combining the technical means disclosed in different embodiments.
すなわち、本発明の一実施形態は、以下である。
<1>(a)-5℃以下、-20℃以上の水酸化ナトリウム、水酸化リチウム、尿素及び水の混和溶液にセルロースを溶解させ、セルロース溶液を調製する工程、
(b)前記セルロース溶液を10℃以上、40℃以下に加温する工程、
(c)前記セルロース溶液を10℃以上、40℃以下の分散媒に分散させてエマルションを作製する工程、
(d)前記エマルションを凝固溶媒に接触させ、セルロースビーズを析出させる工程、
(e)析出したセルロースビーズを架橋する工程を含むことを特徴とする、多孔質架橋セルロースビーズの製造方法であり、
前記工程(a)の水酸化ナトリウム/水酸化リチウムのモル比が0.3/0.7~0.8/0.2であることを特徴とする多孔質架橋セルロースビーズの製造方法。
<2>前記工程(a)の水酸化ナトリウム、水酸化リチウム、尿素及び水の混和溶液の尿素濃度が10重量%~20重量%であることを特徴とする多孔質架橋セルロースビーズの製造方法。
<3>前期セルロース溶液のセルロース濃度が3重量%以上、9重量%以下であることを特徴とする、多孔質架橋セルロースビーズ製造方法
<4>前記凝固溶媒が、アルコール系溶媒、または水とアルコール系溶媒との混合溶媒であることを特徴とする多孔質架橋セルロースビーズの製造方法。
<5>粒子内空孔率が90%以上、細孔半径が35nm~50nm、及び体積メジアン径が45μm~70μmであることを特徴とする多孔質架橋セルロースビーズ。
That is, one embodiment of the present invention is as follows.
<1> (a) a step of dissolving cellulose in a mixed solution of sodium hydroxide, lithium hydroxide, urea and water at a temperature of −5° C. or lower and −20° C. or higher to prepare a cellulose solution;
(b) heating the cellulose solution to 10° C. or higher and 40° C. or lower;
(c) dispersing the cellulose solution in a dispersion medium at a temperature of 10° C. or higher and 40° C. or lower to prepare an emulsion;
(d) contacting the emulsion with a coagulation solvent to precipitate cellulose beads;
(e) a process for producing porous crosslinked cellulose beads, comprising the step of crosslinking the precipitated cellulose beads,
A method for producing porous crosslinked cellulose beads, characterized in that the molar ratio of sodium hydroxide/lithium hydroxide in the step (a) is 0.3/0.7 to 0.8/0.2.
<2> A method for producing porous crosslinked cellulose beads, characterized in that the urea concentration in the mixed solution of sodium hydroxide, lithium hydroxide, urea and water in the step (a) is 10% by weight to 20% by weight.
<3> A method for producing porous crosslinked cellulose beads, characterized in that the cellulose concentration of the cellulose solution is 3% by weight or more and 9% by weight or less. <4> A method for producing porous crosslinked cellulose beads, characterized in that the coagulation solvent is an alcohol-based solvent or a mixed solvent of water and an alcohol-based solvent.
<5> Porous crosslinked cellulose beads having an intraparticle porosity of 90% or more, a pore radius of 35 nm to 50 nm, and a volume median diameter of 45 μm to 70 μm.
以下、本発明を実施例に基づいてより詳細に説明するが、本発明はこれら実施例に限定されるものではない。 The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples.
〔測定および評価方法〕
実施例、比較例および製造例における測定および評価を、以下の方法で行った。
[Measurement and evaluation methods]
Measurements and evaluations in the Examples, Comparative Examples, and Production Examples were carried out by the following methods.
(体積メジアン径)
本ビーズの体積メジアン径は、HORIBA製レーザ回折/散乱式粒子径分布測定装置LA-950を用いて測定した。
(Volume Median Diameter)
The volume median diameter of the beads was measured using a HORIBA LA-950 laser diffraction/scattering type particle size distribution measuring device.
(細孔半径)
本ビーズ22.8mLを蒸留水に分散させ、30分間脱気した。脱気した多孔質セルロースビーズをカラム(GEヘルスケア・ジャパン社製「Tricorn 10/300」)に充填した。島津製作所社製のサイズ排除クロマトグラフィーシステム(「DGU-20A3」、「RID-10A」、「LC-20AD」、「SIL-20AC」、「CTO-20AC」を含み、ソフトウェアとしては「LCSolution」を使用)を用いて測定を行った。
(Pore radius)
22.8 mL of the beads were dispersed in distilled water and degassed for 30 minutes. The degassed porous cellulose beads were packed into a column (GE Healthcare Japan's "Tricorn 10/300"). Measurements were performed using a Shimadzu Corporation size exclusion chromatography system (including "DGU-20A3", "RID-10A", "LC-20AD", "SIL-20AC", and "CTO-20AC", and using "LCSolution" software).
マーカーとしては、表1に示すデキストランまたはグルコースを、0.2M NaClを含む20mMリン酸バッファ(pH7.5)に溶解して用いた。 As markers, dextran or glucose shown in Table 1 was dissolved in 20 mM phosphate buffer (pH 7.5) containing 0.2 M NaCl.
カラムに0.2M NaClを含む20mMリン酸バッファ(pH7.5)を流速0.33mL/minで通液しながら、先ず、カラム中のビーズ部分以外の体積を求めるために、分子量4×107のデキストランの溶液を注入し、注入からRIモニターでピークが観測されるまでの通液量を求めた。分子量4×107のデキストランの溶液の濃度は10mg/mL、注入量は40μLとした。次いで、各マーカーの溶液でも同様に通液量を求めた。測定値を下記式に代入し、KDの値を算出した。
KD=(VR-V0)/(Vt-V0)
[式中、VRは各マーカー溶液を注入してからピークが観測されるまでの通液量(mL)を示し、V0は分子量4×107のデキストラン溶液を注入してからピークが観測されるまでの通液量(mL)を示し、Vtはカラム内のビーズ細孔の体積(mL)を示す。Vtは分子量180のマーカーより測定される。]
粒子内空孔率は(Vt-V0)/V0で表される。
While passing 20 mM phosphate buffer (pH 7.5) containing 0.2 M NaCl through the column at a flow rate of 0.33 mL/min, a solution of dextran with a molecular weight of 4 x 10 7 was injected to determine the volume of the column other than the bead portion, and the amount of passing was determined from the injection until a peak was observed on the RI monitor. The concentration of the solution of dextran with a molecular weight of 4 x 10 7 was 10 mg/mL, and the injection amount was 40 μL. Next, the amount of passing was determined in the same manner for each marker solution. The measured value was substituted into the following formula to calculate the value of K D.
K D = (V R - V 0 )/(V t - V 0 )
[In the formula, V R indicates the amount of solution (mL) passed from the injection of each marker solution until a peak is observed, V 0 indicates the amount of solution (mL) passed from the injection of a dextran solution with a molecular weight of 4×10 7 until a peak is observed, and V t indicates the volume (mL) of the bead pore in the column. V t is measured from a marker with a molecular weight of 180.]
The intraparticle porosity is expressed as (V t −V 0 )/V 0 .
KDの値より非特許文献4記載の下記式で細孔半径を算出した。 The pore radius was calculated from the KD value using the following formula described in Non-Patent Document 4.
rpは平均細孔半径を、spは標準偏差を示す。 rp denotes the average pore radius, and s p denotes the standard deviation.
(動的吸着量の測定)
(1) 溶液調製
下記A~E液及び中和液を調製し、使用前に脱泡した。
A液: シグマ社製「Phosphate buffered saline」と蒸留水を用いてpH7.4のPBS緩衝液を調製した。
B液: 酢酸、酢酸ナトリウム、および蒸留水を用いてpH3.5の35mM酢酸ナトリウム水溶液を調製した。
C液: 酢酸と蒸留水を用いて1M酢酸水溶液を調製した。
D液: ポリクロナール抗体(「ガンマガード」バクスター社製)と前記A液を用いて濃度3mg/mLのIgG水溶液を調製した。
E液: 和光純薬社製の水酸化ナトリウムと塩化ナトリウムの濃度が、それぞれ0.1N水酸化ナトリウムと1M塩化ナトリウムとなる水溶液を作製し、アルカリ洗浄液とした。
中和液: トリス(ヒドロキシメチル)アミノメタンと超純水で2Mのトリス(ヒドロキシメチル)アミノメタン水溶液を調製した。
(Measurement of dynamic adsorption amount)
(1) Solution Preparation The following solutions A to E and a neutralization solution were prepared and degassed before use.
Solution A: A PBS buffer solution of pH 7.4 was prepared using Sigma's "Phosphate buffered saline" and distilled water.
Solution B: A 35 mM aqueous sodium acetate solution at pH 3.5 was prepared using acetic acid, sodium acetate, and distilled water.
Solution C: A 1M aqueous solution of acetic acid was prepared using acetic acid and distilled water.
Solution D: A polyclonal antibody ("Gammaguard", Baxter) and the above solution A were used to prepare an aqueous IgG solution with a concentration of 3 mg/mL.
Solution E: An aqueous solution of sodium hydroxide and sodium chloride manufactured by Wako Pure Chemical Industries, Ltd., with concentrations of 0.1 N sodium hydroxide and 1 M sodium chloride, respectively, was prepared and used as an alkaline cleaning solution.
Neutralizing solution: A 2M aqueous solution of tris(hydroxymethyl)aminomethane was prepared using tris(hydroxymethyl)aminomethane and ultrapure water.
(2) 充填、準備
カラムクロマトグラフィー用装置としてAKTA Pure 150(GEヘルスケア社製)を用い、内径0.5cmのカラムに吸着体試料を3mL入れ、吸着体層高さを15cmとした。塩化ナトリウムと蒸留水から調製した0.2MのNaCl水溶液を流速3mL/分で10分間通液して吸着体をカラムに充填した。フラクションコレクターに15mLの採取用チューブをセットし、溶出液の採取用チューブにはあらかじめ中和液を入れておいた。
(2) Packing and preparation AKTA Pure 150 (GE Healthcare) was used as a column chromatography apparatus, and 3 mL of the adsorbent sample was placed in a column with an inner diameter of 0.5 cm, and the adsorbent layer height was set to 15 cm. A 0.2 M NaCl aqueous solution prepared from sodium chloride and distilled water was passed through the column at a flow rate of 3 mL/min for 10 minutes to pack the adsorbent into the column. A 15 mL collection tube was set in the fraction collector, and a neutralizing solution was previously placed in the collection tube for the eluate.
(3) IgG精製
前記カラムにA液を15mL通液し、次いでD液を必要量通液した。次いで、A液を12mL通液後、B液を12mL通液してIgGを溶出させた。次にC液を9mL、A液を15mL、E液を9mL、A液を15mL通液した。なお流速はD液以外は1mL/minとし、D液の流速は所定の滞留時間(RT)に合わせた。例えばRT4分の流速は0.75mL/minに調整した。
(3) IgG purification 15 mL of solution A was passed through the column, and then the required amount of solution D was passed through. Next, 12 mL of solution A was passed through, and then 12 mL of solution B was passed through to elute IgG. Next, 9 mL of solution C, 15 mL of solution A, 9 mL of solution E, and 15 mL of solution A were passed through. The flow rate was 1 mL/min except for solution D, and the flow rate of solution D was adjusted to a predetermined retention time (RT). For example, the flow rate at RT 4 minutes was adjusted to 0.75 mL/min.
(4) 動的吸着量
IgGが5%破過するまでに吸着体に吸着したIgG量と吸着体体積からIgGの動的吸着量を求めた。当該動的吸着量を5%DBCという。
(4) Dynamic adsorption amount The dynamic adsorption amount of IgG was calculated from the amount of IgG adsorbed to the adsorbent until 5% of IgG broke through and the volume of the adsorbent. This dynamic adsorption amount is called 5% DBC.
〔実施例1〕
(セルロース溶液の調製)
48.0wt%水酸化ナトリウム(ナカライテスク株式会社製)水溶液30.2gと水酸化リチウム1水和物(キシダ化学株式会社製)15.4g、尿素(和光純薬株式会社製)57.5g、純水200gを混合、溶解させ10℃に保持し、アルカリ水溶液を作製した。粉末状のセルロース(日本製紙製、W200G)17gを80gの水に分散させ、前記アルカリ水溶液に添加した後、-12℃まで温度を下げ、セルロースを溶解させた。セルロース重量を除いた溶媒の水酸化ナトリウム濃度は3.8重量%、水酸化リチウム濃度は2.3重量%、尿素濃度は15重量%であり、水酸化ナトリウムモル量/水酸化リチウムモル量は0.5/0.5である。セルロース溶液を60分間、-12℃で保持した後、40℃に加温し30分間保持した。
Example 1
(Preparation of cellulose solution)
30.2 g of 48.0 wt% sodium hydroxide (manufactured by Nacalai Tesque, Inc.) aqueous solution, 15.4 g of lithium hydroxide monohydrate (manufactured by Kishida Chemical Co., Ltd.), 57.5 g of urea (manufactured by Wako Pure Chemical Industries, Ltd.), and 200 g of pure water were mixed and dissolved, and kept at 10 ° C. to prepare an alkaline aqueous solution. 17 g of powdered cellulose (manufactured by Nippon Paper Industries, W200G) was dispersed in 80 g of water and added to the alkaline aqueous solution, and then the temperature was lowered to -12 ° C. to dissolve the cellulose. The sodium hydroxide concentration of the solvent excluding the cellulose weight was 3.8 wt%, the lithium hydroxide concentration was 2.3 wt%, the urea concentration was 15 wt%, and the sodium hydroxide molar amount / lithium hydroxide molar amount was 0.5 / 0.5. The cellulose solution was kept at -12 ° C. for 60 minutes, and then heated to 40 ° C. and kept for 30 minutes.
(多孔質セルロースビーズの作製)
ハイコールK―230(流動パラフィン、カネダ株式会社製)234.5gとハイコールK―290(流動パラフィン、カネダ株式会社製)404.5g、PR-100(理研ビタミン製)9.8gを内径85 mmの円筒型容器に入れ、300rpmで攪拌し、40℃とし、上記セルロース溶液161gを添加、攪拌することでエマルションを作製した。攪拌は3段攪拌翼を用い、上から傾斜パドル、フラットタービン、ディスクタービンである。20分撹拌し、メタノール/純水体積比70/30の凝固溶媒を150 ml添加し、セルロースビーズを得た。得られたセルロースビーズはイソプロパノールで洗浄した後、水で洗浄した。
(Preparation of Porous Cellulose Beads)
234.5 g of Hicol K-230 (liquid paraffin, manufactured by Kaneda Co., Ltd.), 404.5 g of Hicol K-290 (liquid paraffin, manufactured by Kaneda Co., Ltd.), and 9.8 g of PR-100 (manufactured by Riken Vitamin Co., Ltd.) were placed in a cylindrical container with an inner diameter of 85 mm, stirred at 300 rpm, heated to 40°C, and 161 g of the above cellulose solution was added and stirred to prepare an emulsion. A three-stage stirring blade was used for stirring, with an inclined paddle, a flat turbine, and a disk turbine from the top. After stirring for 20 minutes, 150 ml of a coagulation solvent with a methanol/pure water volume ratio of 70/30 was added to obtain cellulose beads. The obtained cellulose beads were washed with isopropanol and then with water.
(セルロースビーズの分級)
得られた残りのセルロースビーズを櫛目開き38μmと櫛目開き90μmメッシュを用いて篩分けし、38μmから90μmの範囲のビーズを集めた。
(Classification of cellulose beads)
The remaining cellulose beads obtained were sieved using meshes with 38 μm and 90 μm openings to collect beads in the range of 38 μm to 90 μm.
(セルロースビーズの架橋)
分級後の多孔質セルロースビーズに含まれる液体部100mLをエタノールで置換した後、反応容器に移し、セルロース粒子とエタノールの合計量が125gとなるようにし、そこにエピクロロヒドリン80mLを添加した。溶液温度を40℃に調整し、1.8N NaOH水溶液(ナカライテスク社製水酸化ナトリウムと蒸留水で調製)を96mL添加し、架橋反応を開始させた。反応開始から1.5時間後に17.0N NaOH水溶液を9.6mL添加し、反応開始から3時間後と4.5時間後にも17.0N NaOH水溶液を9.6mL添加した。反応開始から6時間後にゲルを回収し、ビーズの20倍体積量以上の蒸留水で洗浄した。
(Cross-linking of cellulose beads)
After replacing 100 mL of the liquid contained in the porous cellulose beads after classification with ethanol, the mixture was transferred to a reaction vessel so that the total amount of cellulose particles and ethanol was 125 g, and 80 mL of epichlorohydrin was added thereto. The solution temperature was adjusted to 40°C, and 96 mL of 1.8 N NaOH aqueous solution (prepared with sodium hydroxide and distilled water manufactured by Nacalai Tesque) was added to start the crosslinking reaction. 1.5 hours after the start of the reaction, 9.6 mL of 17.0 N NaOH aqueous solution was added, and 3 hours and 4.5 hours after the start of the reaction, 9.6 mL of 17.0 N NaOH aqueous solution was also added. 6 hours after the start of the reaction, the gel was collected and washed with distilled water with a volume 20 times or more that of the beads.
上記架橋反応で得られた架橋セルロースビーズを反応容器に移し、セルロースビーズと蒸留水の合計量が116.7gとなるようにした。そこに硫酸ナトリウムを37.8g添加、溶解させた後、エピクロロヒドリンを33mL添加し、40℃で保持した。17.0N NaOH水溶液を21mL添加し、架橋反応を開始させ、反応開始から2.5時間後に17.0N NaOH水溶液を5mL添加した。反応開始から5時間後に粒子を回収し、粒子の20倍体積量以上の蒸留水で洗浄した。 The crosslinked cellulose beads obtained by the above crosslinking reaction were transferred to a reaction vessel so that the total amount of cellulose beads and distilled water was 116.7 g. 37.8 g of sodium sulfate was added and dissolved, after which 33 mL of epichlorohydrin was added and the mixture was kept at 40°C. 21 mL of 17.0 N NaOH aqueous solution was added to start the crosslinking reaction, and 2.5 hours after the start of the reaction, 5 mL of 17.0 N NaOH aqueous solution was added. Five hours after the start of the reaction, the particles were collected and washed with distilled water in an amount 20 times the volume of the particles or more.
(多孔質架橋セルロースビーズの分級)
得られた残りのセルロースビーズを櫛目開き38μmと櫛目開き75μmメッシュを用いて篩分けし、38μmから75μmの範囲のビーズを集めた。得られた架橋セルロースビーズの体積メジアン径は61μm、平均細孔半径は45.0nm、粒子内空孔率は98%だった。
(Classification of porous cross-linked cellulose beads)
The remaining cellulose beads were sieved using a 38 μm mesh and a 75 μm mesh to collect beads in the range of 38 μm to 75 μm in size. The crosslinked cellulose beads had a volume median diameter of 61 μm, an average pore radius of 45.0 nm, and an intraparticle porosity of 98%.
〔実施例2〕
セルロース溶液調製時の加温温度と多孔質セルロースビーズの作製の温度を25℃にした以外は実施例1と同様の方法で、架橋セルロースビーズを得た。得られた架橋セルロースビーズの体積メジアン径は60μm、平均細孔半径は38.4nm、粒子内空孔率は97%だった。
Example 2
Crosslinked cellulose beads were obtained in the same manner as in Example 1, except that the heating temperature during preparation of the cellulose solution and the temperature during preparation of the porous cellulose beads were both 25° C. The resulting crosslinked cellulose beads had a volume median diameter of 60 μm, an average pore radius of 38.4 nm, and an intraparticle porosity of 97%.
〔実施例3〕
セルロース溶液調製時の尿素濃度を11.5重量%以外は実施例1と同様の方法で、架橋セルロースビーズを得た。得られた架橋セルロースビーズの体積メジアン径は60μm、平均細孔半径は41.9nm、粒子内空孔率は98%だった。
Example 3
Crosslinked cellulose beads were obtained in the same manner as in Example 1, except that the urea concentration during preparation of the cellulose solution was 11.5% by weight. The resulting crosslinked cellulose beads had a volume median diameter of 60 μm, an average pore radius of 41.9 nm, and an intraparticle porosity of 98%.
〔実施例4〕
48.0wt%水酸化ナトリウム水溶液45.3gと水酸化リチウム1水和物7.7g、尿素57.5g、純水200gを混合、溶解させ10℃に保持し、アルカリ水溶液を作製した。粉末状のセルロース17gを80gの水に分散させ、前記アルカリ水溶液に添加した後、-12℃まで温度を下げ、セルロースを溶解させた。セルロース重量を除いた溶媒の水酸化ナトリウム濃度は5.6重量%、水酸化リチウム濃度は1.1重量%、尿素濃度は15重量%であり、水酸化ナトリウムモル量/水酸化リチウムモル量は0.25/0.75である。セルロース溶液を60分間、-12℃で保持した後、40℃に加温し30分間保持した。それ以外は実施例1と同様の方法で、架橋セルロースビーズを得た。得られた架橋セルロースビーズの体積メジアン径は60μm、平均細孔半径は39.9nm、粒子内空孔率は98%だった。
Example 4
45.3 g of 48.0 wt% sodium hydroxide aqueous solution, 7.7 g of lithium hydroxide monohydrate, 57.5 g of urea, and 200 g of pure water were mixed, dissolved, and held at 10 ° C to prepare an alkaline aqueous solution. 17 g of powdered cellulose was dispersed in 80 g of water, added to the alkaline aqueous solution, and then the temperature was lowered to -12 ° C to dissolve the cellulose. The sodium hydroxide concentration of the solvent excluding the cellulose weight was 5.6 wt%, the lithium hydroxide concentration was 1.1 wt%, the urea concentration was 15 wt%, and the sodium hydroxide molar amount / lithium hydroxide molar amount was 0.25 / 0.75. The cellulose solution was held at -12 ° C for 60 minutes, and then heated to 40 ° C and held for 30 minutes. Except for this, crosslinked cellulose beads were obtained in the same manner as in Example 1. The volume median diameter of the obtained crosslinked cellulose beads was 60 μm, the average pore radius was 39.9 nm, and the intraparticle porosity was 98%.
〔実施例5〕
多孔質セルロースビーズの作製時にメタノール/純水体積比45/55の凝固溶媒を150 ml添加した以外は、実施例4と同様の方法で、架橋セルロースビーズを得た。得られた架橋セルロースビーズの体積メジアン径は62μm、平均細孔半径は40.7nm、粒子内空孔率は94%だった。
Example 5
Crosslinked cellulose beads were obtained in the same manner as in Example 4, except that 150 ml of a coagulation solvent having a methanol/pure water volume ratio of 45/55 was added when preparing the porous cellulose beads. The resulting crosslinked cellulose beads had a volume median diameter of 62 μm, an average pore radius of 40.7 nm, and an intraparticle porosity of 94%.
〔実施例6〕
多孔質セルロースビーズの作製時にセルロース量を14gとした以外は、実施例1と同様の方法で、架橋セルロースビーズを得た。得られた架橋セルロースビーズの体積メジアン径は58μm、平均細孔半径は44.9nm、粒子内空孔率は97%だった。
Example 6
Except for changing the amount of cellulose to 14 g when preparing the porous cellulose beads, crosslinked cellulose beads were obtained in the same manner as in Example 1. The volume median diameter of the obtained crosslinked cellulose beads was 58 μm, the average pore radius was 44.9 nm, and the intraparticle porosity was 97%.
〔比較例1〕
48.0wt%水酸化ナトリウム水溶液52.5g、尿素46.0gを混合、溶解させ10℃に保持し、アルカリ水溶液を作製した。粉末状のセルロース17gを283.5gの水に分散させ、前記アルカリ水溶液に添加した後、-12℃まで温度を下げ、セルロースを溶解させた。セルロース重量を除いた溶媒の水酸化ナトリウム濃度は6.7重量%、尿素濃度は12重量%である。セルロース溶液を60分間、-12℃で保持した後、40℃に加温し30分間保持した。それ以外は実施例1と同様の方法で、架橋セルロースビーズを得た。得られた架橋セルロースビーズの体積メジアン径は60μm、平均細孔半径は51.2nm、粒子内空孔率は90%だった。
Comparative Example 1
52.5 g of 48.0 wt % sodium hydroxide aqueous solution and 46.0 g of urea were mixed and dissolved and kept at 10 ° C to prepare an alkaline aqueous solution. 17 g of powdered cellulose was dispersed in 283.5 g of water, added to the alkaline aqueous solution, and then the temperature was lowered to -12 ° C to dissolve the cellulose. The sodium hydroxide concentration of the solvent excluding the cellulose weight was 6.7 wt % and the urea concentration was 12 wt %. The cellulose solution was kept at -12 ° C for 60 minutes, and then heated to 40 ° C and kept for 30 minutes. Except for this, crosslinked cellulose beads were obtained in the same manner as in Example 1. The volume median diameter of the obtained crosslinked cellulose beads was 60 μm, the average pore radius was 51.2 nm, and the intraparticle porosity was 90%.
〔比較例2〕
水酸化リチウム1水和物31.0g、尿素57.5g、純水210gを混合、溶解させ10℃に保持し、アルカリ水溶液を作製した。粉末状のセルロース17gを80gの水に分散させ、前記アルカリ水溶液に添加した後、-12℃まで温度を下げ、セルロースを溶解させた。セルロース重量を除いた溶媒の水酸化リチウム濃度は4.7重量%、尿素濃度は15.2重量%である。それ以外は実施例2と同様の方法で、架橋セルロースビーズを得た。得られた架橋セルロースビーズの体積メジアン径は58μm、平均細孔半径は28.0nm、粒子内空孔率は95%だった。
Comparative Example 2
31.0 g of lithium hydroxide monohydrate, 57.5 g of urea, and 210 g of pure water were mixed and dissolved, and the mixture was kept at 10°C to prepare an alkaline aqueous solution. 17 g of powdered cellulose was dispersed in 80 g of water, and the mixture was added to the alkaline aqueous solution, and then the temperature was lowered to -12°C to dissolve the cellulose. The lithium hydroxide concentration of the solvent excluding the cellulose weight was 4.7 wt%, and the urea concentration was 15.2 wt%. Except for this, crosslinked cellulose beads were obtained in the same manner as in Example 2. The volume median diameter of the obtained crosslinked cellulose beads was 58 μm, the average pore radius was 28.0 nm, and the intraparticle porosity was 95%.
〔比較例3〕
水酸化リチウム1水和物31.5g、尿素46.0g、純水137.3gを混合、溶解させ10℃に保持し、アルカリ水溶液を作製した。粉末状のセルロース17gを170gの水に分散させ、前記アルカリ水溶液に添加した後、-12℃まで温度を下げ、セルロースを溶解させた。セルロース重量を除いた溶媒の水酸化リチウム濃度は4.7重量%、尿素濃度は12.0重量%である。セルロース溶液を60分間、-12℃で保持した後、40℃に加温し30分間保持した。それ以外は実施例1と同様の方法で、架橋セルロースビーズを得た。得られた架橋セルロースビーズの体積メジアン径は60μm、平均細孔半径は33.8nm、粒子内空孔率は98%だった。
Comparative Example 3
31.5 g of lithium hydroxide monohydrate, 46.0 g of urea, and 137.3 g of pure water were mixed and dissolved, and the mixture was kept at 10°C to prepare an alkaline aqueous solution. 17 g of powdered cellulose was dispersed in 170 g of water, and the mixture was added to the alkaline aqueous solution, and then the temperature was lowered to -12°C to dissolve the cellulose. The lithium hydroxide concentration of the solvent excluding the cellulose weight was 4.7% by weight, and the urea concentration was 12.0% by weight. The cellulose solution was kept at -12°C for 60 minutes, and then heated to 40°C and kept for 30 minutes. Except for this, crosslinked cellulose beads were obtained in the same manner as in Example 1. The volume median diameter of the obtained crosslinked cellulose beads was 60 μm, the average pore radius was 33.8 nm, and the intraparticle porosity was 98%.
〔試験例〕
実施例1から5、比較例1から2で得られた多孔質架橋セルロースビーズを下記方法で、プロテインAリガンドを結合させた。
[Test Example]
The porous cross-linked cellulose beads obtained in Examples 1 to 5 and Comparative Examples 1 and 2 were bound to a protein A ligand by the following method.
(エポキシ開環処理)
得られた架橋ビーズと水の50%スラリーをオートクレーブにて121℃、60分間加熱することでエポキシ基を開環し、ジオール基とした。エポキシ基が無くなっていることは、フェノールフタレイン指示薬にて確認することができる。
(Epoxy ring-opening treatment)
The resulting crosslinked beads and 50% slurry of water was heated in an autoclave at 121° C. for 60 minutes to open the epoxy groups and convert them into diol groups. The disappearance of the epoxy groups can be confirmed using a phenolphthalein indicator.
(アルデヒド化反応)
クエン酸一水和物0.165gとクエン酸三ナトリウム二水和物0.0646gに水を加えて100mLとし、pH3.4のバッファーを作製した。
(Aldehyde formation reaction)
A buffer having a pH of 3.4 was prepared by adding water to 0.165 g of citric acid monohydrate and 0.0646 g of trisodium citrate dihydrate to make 100 mL.
架橋後のセルロースビーズ3.5mLに対して上記バッファーを3倍量以上用いて液体部分を上記バッファーで置換し、更に上記バッファーを加えて総量を6.0mLとした。11.2mg/mLの過ヨウ素酸ナトリウム水溶液を2.01mL投入し、25℃で35分間攪拌した。その後、#3のグラスフィルターにて濾過を行ない、蒸留水で濾液の電気伝導度が1μS/cm以下となるまで洗浄し、アルデヒド基含有ビーズを得た。洗浄濾液の電気伝導度は、導電率計(「ECTester10 Pure+」EUTECH INSTRUMENTS社製)で測定した。本反応条件にて、架橋多孔質セルロースビーズ1mLあたり約30μmolのアルデヒド基が導入される。 For 3.5 mL of crosslinked cellulose beads, the liquid portion was replaced with the above buffer using at least three times the amount, and the above buffer was further added to make the total amount 6.0 mL. 2.01 mL of 11.2 mg/mL aqueous sodium periodate solution was added and stirred at 25°C for 35 minutes. After that, it was filtered with a #3 glass filter and washed with distilled water until the electrical conductivity of the filtrate was 1 μS/cm or less, and beads containing aldehyde groups were obtained. The electrical conductivity of the washed filtrate was measured with a conductivity meter ("ECTester10 Pure+" manufactured by EUTECH INSTRUMENTS). Under these reaction conditions, approximately 30 μmol of aldehyde groups were introduced per 1 mL of crosslinked porous cellulose beads.
(プロテインA固定化反応)
<配向制御型アルカリ耐性プロテインAの調製>
WO2012/133349を参照して、配向制御型アルカリ耐性プロテインAとして、WO2012/133349に記載の改変Cドメイン5連結体を調製した。配向制御型アルカリ耐性プロテインAは、配列番号2で示されるアミノ酸配列を有する。なお、このWO2012/133349の全内容が、本願に参考のため援用される。以下、「プロテインA」を「PA」と略記する。
(Protein A immobilization reaction)
<Preparation of orientation-controlled alkaline-resistant protein A>
With reference to WO2012/133349, the modified C domain 5-conjugate described in WO2012/133349 was prepared as orientation-controlled alkali-resistant protein A. The orientation-controlled alkali-resistant protein A has the amino acid sequence shown in SEQ ID NO: 2. The entire contents of WO2012/133349 are incorporated herein by reference. Hereinafter, "protein A" will be abbreviated as "PA".
<イミノ化反応-PA仕込量が20mg/mLの場合>
クエン酸三ナトリウム二水和物2.941gに水を加えて100mLとし、pH8のバッファーを作製した。#3のグラスフィルター上でアルデヒド基含有ビーズの全量(3.5mL)に対して3倍量の前記バッファーを通液して、ビーズ内の液体部分を上記バッファーで置換した。置換後のアルデヒド基含有ビーズを反応容器に入れ、総体積が7.5mLとなるようにPA固定化バッファーを添加した。プロテインAをビーズ1mLに対して20mg(正味量)添加した。6℃に温調後、0.08Nの水酸化ナトリウム水溶液を用いて、pHを12に調整した後、6℃にて一晩攪拌した。
<Imination reaction - when PA amount is 20 mg/mL>
Water was added to 2.941 g of trisodium citrate dihydrate to make 100 mL, and a buffer of pH 8 was prepared. The above buffer was passed through the aldehyde group-containing beads in an amount three times the total amount (3.5 mL) on a #3 glass filter, and the liquid portion in the beads was replaced with the above buffer. The aldehyde group-containing beads after replacement were placed in a reaction vessel, and a PA immobilization buffer was added so that the total volume became 7.5 mL. Protein A was added in an amount of 20 mg (net amount) per 1 mL of beads. After adjusting the temperature to 6°C, the pH was adjusted to 12 using a 0.08 N aqueous sodium hydroxide solution, and then stirred at 6°C overnight.
<中和および還元反応>
一晩反応後のイミノ化反応液を濾過し、濾液をUV測定してPA固定化量を求めた。前記pH8.0のクエン酸Naバッファーに、0.1Mのクエン酸水溶液を加えて、pHを5.0に調整したバッファーを作製し、前記濾過ビーズに対して3倍量の当該バッファーを用い、ビーズ内の液体部分を置換した。p5.0のバッファーで総量を7.0mLに調整しながら反応器に移し、4時間6℃で中和を保持しながら攪拌した。
Neutralization and reduction reactions
The imino reaction solution after overnight reaction was filtered, and the filtrate was measured by UV to determine the amount of PA immobilized. A 0.1 M aqueous citric acid solution was added to the pH 8.0 Na citrate buffer to prepare a buffer adjusted to pH 5.0, and the liquid portion in the beads was replaced using the buffer in an amount three times that of the filtration beads. The total volume was adjusted to 7.0 mL with a pH 5.0 buffer and transferred to a reactor, and the mixture was stirred at 6° C. for 4 hours while maintaining neutrality.
その後、5.5%ジメチルアミンボラン水溶液を1.93mL加えた後、反応温度を25℃に上昇させ、25℃で一晩攪拌した。反応後のビーズを#3のグラスフィルター上で、ビーズの3倍体積量の水で洗浄した。 After that, 1.93 mL of 5.5% dimethylamine borane aqueous solution was added, and the reaction temperature was raised to 25°C and stirred at 25°C overnight. After the reaction, the beads were washed on a #3 glass filter with water in an amount three times the volume of the beads.
<洗浄>
#3のグラスフィルター上でPA固定化ビーズ1mLに対して3mLの0.1Mクエン酸(以下「酸バッファー」と略記する)を通液して、ビーズ内の液体部分を酸バッファーで置換した。置換後のPA固定化ビーズを容器に移し、酸バッファーを加えて全量を2mL以上とし、25℃で30分間攪拌し、酸洗浄とした。
<Cleaning>
On a #3 glass filter, 3 mL of 0.1 M citric acid (hereinafter referred to as "acid buffer") was passed through 1 mL of PA-immobilized beads to replace the liquid portion in the beads with the acid buffer. The PA-immobilized beads after the replacement were transferred to a container, and the acid buffer was added to make the total amount 2 mL or more, and the mixture was stirred at 25°C for 30 minutes to perform acid washing.
次いで、上記酸バッファーの代わりに0.05N水酸化ナトリウム+1M硫酸ナトリウム水溶液を用いた以外は同様の方法でアルカリ洗浄を行なった。 Next, alkaline washing was performed in the same manner, except that an aqueous solution of 0.05 N sodium hydroxide + 1 M sodium sulfate was used instead of the acid buffer.
次いで、上記酸バッファーの代わりに、0.1Mクエン酸と0.1Mクエン酸ナトリウムを混合してpHを5.9に調整した液を用いた以外は、同様の方法で中性洗浄を行なった。 Next, neutral washing was performed in the same manner, except that instead of the acid buffer, a solution made by mixing 0.1 M citric acid and 0.1 M sodium citrate and adjusting the pH to 5.9 was used.
中性洗浄後のビーズを蒸留水を用いて洗浄濾液の電導度が10μs/cm以下になるまで洗浄し、プロテインAが固定化された吸着体を得た。 After neutral washing, the beads were washed with distilled water until the electrical conductivity of the washing filtrate was 10 μs/cm or less, yielding an adsorbent with immobilized Protein A.
得られた吸着体のRT4分の5%DBCを表2に示す。 The 5% DBC of the resulting adsorbent at RT4 minutes is shown in Table 2.
〔結果〕
表2より、実施例では、比較例に比して、高い抗体吸着性能を持つことが示された。また、セルロース溶液の水酸化ナトリウムモル量/水酸化リチウムモル量が特定の範囲でのみ、抗体吸着にとって好適な細孔半径を持つことが示された。
〔result〕
Table 2 shows that the Examples have higher antibody adsorption performance than the Comparative Examples. It also shows that the pore radius is suitable for antibody adsorption only when the molar amount of sodium hydroxide/molar amount of lithium hydroxide in the cellulose solution is in a specific range.
以上より、本製造方法によると、高い抗体吸着能力を有する多孔質架橋セルロースビーズを製造することができることが分かった。 From the above, it was found that this manufacturing method can produce porous cross-linked cellulose beads with high antibody adsorption capacity.
Claims (4)
(b)前記セルロース溶液を10℃以上、40℃以下に加温する工程、
(c)前記セルロース溶液を10℃以上、40℃以下の分散媒に分散させてエマルションを作製する工程、
(d)前記エマルションを凝固溶媒に接触させ、セルロースビーズを析出させる工程、
(e)析出したセルロースビーズを架橋する工程を含むことを特徴とする、多孔質架橋セルロースビーズの製造方法であり、
前記工程(a)の水酸化ナトリウム/水酸化リチウムのモル比が0.3/0.7~0.8/0.2であることを特徴とする多孔質架橋セルロースビーズの製造方法。 (a) preparing a cellulose solution by dissolving cellulose in a mixed solution of sodium hydroxide, lithium hydroxide, urea and water at a temperature of −5° C. or lower and −20° C. or higher;
(b) heating the cellulose solution to 10° C. or higher and 40° C. or lower;
(c) dispersing the cellulose solution in a dispersion medium having a temperature of 10° C. or higher and 40° C. or lower to prepare an emulsion;
(d) contacting the emulsion with a coagulation solvent to precipitate cellulose beads;
(e) a process for producing porous crosslinked cellulose beads, comprising the step of crosslinking the precipitated cellulose beads,
A method for producing porous crosslinked cellulose beads, characterized in that the molar ratio of sodium hydroxide/lithium hydroxide in the step (a) is 0.3/0.7 to 0.8/0.2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020064177A JP7629692B2 (en) | 2020-03-31 | 2020-03-31 | Method for producing porous cellulose beads |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020064177A JP7629692B2 (en) | 2020-03-31 | 2020-03-31 | Method for producing porous cellulose beads |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021161246A JP2021161246A (en) | 2021-10-11 |
| JP7629692B2 true JP7629692B2 (en) | 2025-02-14 |
Family
ID=78004499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020064177A Active JP7629692B2 (en) | 2020-03-31 | 2020-03-31 | Method for producing porous cellulose beads |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7629692B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2024106527A1 (en) | 2022-11-17 | 2024-05-23 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102794161A (en) | 2012-09-10 | 2012-11-28 | 重庆希尔康血液净化器材研发有限公司 | Porous cellulose microsphere adsorbent used for blood perfusion and preparation method thereof |
| WO2015142159A1 (en) | 2014-03-17 | 2015-09-24 | Universiti Kebangsaan Malaysia | A method for preparing a cellulose based material |
| JP2016153449A (en) | 2015-02-20 | 2016-08-25 | 株式会社カネカ | Method for manufacturing porous cellulose particle |
| WO2016167268A1 (en) | 2015-04-15 | 2016-10-20 | 株式会社カネカ | Method for producing porous cellulose beads, and adsorbent using same |
| WO2017141910A1 (en) | 2016-02-15 | 2017-08-24 | 東ソー株式会社 | Porous crosslinked cellulose gel and manufacturing method for same |
| WO2020121805A1 (en) | 2018-12-12 | 2020-06-18 | 株式会社ダイセル | Method for producing cellulose beads |
| WO2021024900A1 (en) | 2019-08-02 | 2021-02-11 | 株式会社ダイセル | Porous cellulose particles and production method therefor |
-
2020
- 2020-03-31 JP JP2020064177A patent/JP7629692B2/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102794161A (en) | 2012-09-10 | 2012-11-28 | 重庆希尔康血液净化器材研发有限公司 | Porous cellulose microsphere adsorbent used for blood perfusion and preparation method thereof |
| WO2015142159A1 (en) | 2014-03-17 | 2015-09-24 | Universiti Kebangsaan Malaysia | A method for preparing a cellulose based material |
| JP2016153449A (en) | 2015-02-20 | 2016-08-25 | 株式会社カネカ | Method for manufacturing porous cellulose particle |
| WO2016167268A1 (en) | 2015-04-15 | 2016-10-20 | 株式会社カネカ | Method for producing porous cellulose beads, and adsorbent using same |
| WO2017141910A1 (en) | 2016-02-15 | 2017-08-24 | 東ソー株式会社 | Porous crosslinked cellulose gel and manufacturing method for same |
| WO2020121805A1 (en) | 2018-12-12 | 2020-06-18 | 株式会社ダイセル | Method for producing cellulose beads |
| WO2021024900A1 (en) | 2019-08-02 | 2021-02-11 | 株式会社ダイセル | Porous cellulose particles and production method therefor |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021161246A (en) | 2021-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6506554B2 (en) | Adsorbent and purification method using the same | |
| US9487595B2 (en) | Method for producing porous cellulose beads | |
| JP2016153449A (en) | Method for manufacturing porous cellulose particle | |
| JP5785553B2 (en) | Porous particle production method, porous particle, adsorbent, and protein purification method | |
| US10221211B2 (en) | Process for producing porous cellulose beads using alkali aqueous solution | |
| JP6231032B2 (en) | Method for producing cellulose porous particles and cellulose porous particles | |
| US20180056271A1 (en) | Method for producing porous cellulose beads, and adsorbent using same | |
| JP6440320B2 (en) | Method for producing porous cellulose beads and adsorbent using the same | |
| JP7629692B2 (en) | Method for producing porous cellulose beads | |
| JP3601229B2 (en) | Porous spherical cellulose particles | |
| JP2021121647A (en) | Porous cellulose beads and method for producing adsorbent | |
| JP6442409B2 (en) | Method for producing porous cellulose beads | |
| WO2013180176A1 (en) | Endotoxin adsorbent | |
| JP6517145B2 (en) | Method of producing porous cellulose beads and adsorbent using the same | |
| WO2023032346A1 (en) | Porous particles, method for producing same, and filler for chromatography using same | |
| JP2005199203A (en) | Non-particulate organic porous body having optical resolution ability and its manufacturing method | |
| JPWO2018186222A1 (en) | Porous cellulose beads and adsorbent | |
| BR102017018275B1 (en) | PROCESS FOR OBTAINING ADSORBENT PARTICLES, ADSORBENT PARTICLES AND THEIR USE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230127 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20231114 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240109 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240305 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20240305 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240426 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20240426 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240730 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240927 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250107 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250203 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7629692 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |